| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013250679 |
| P356 | DOI | 10.1007/S12325-012-0050-8 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s12325-012-0050-8 |
| P698 | PubMed publication ID | 23054689 |
| P5875 | ResearchGate publication ID | 232231326 |
| P50 | author | Craig R Rayner | Q97641254 |
| Regina Dutkowski | Q104774590 | ||
| Markus Britschgi | Q42292898 | ||
| P2093 | author name string | Stephen Toovey | |
| Eric P Prinssen | |||
| Tom Chu | |||
| Barbara Donner | |||
| Alexandra Sirzen-Zelenskaya | |||
| Annette Koerner | |||
| Bharat T Thakrar | |||
| Sudhir Bansod | |||
| P2860 | cites work | MR imaging in novel influenza A(H1N1)-associated meningoencephalitis | Q48310951 |
| Novel influenza A (H1N1) presenting as an acute febrile encephalopathy in a mother and daughter | Q48402113 | ||
| Mild influenza-associated encephalopathy/encephalitis with a reversible splenial lesion in a Caucasian child with additional cerebellar features. | Q48436851 | ||
| Recurrent acute necrotizing encephalopathy following influenza A in a genetically predisposed family. | Q48439800 | ||
| Is a reversible splenial lesion a sign of encephalopathy? | Q48529567 | ||
| Acute necrotizing encephalopathy: a comparison between influenza and non-influenza cases. | Q48607107 | ||
| Delirious behavior in influenza is associated with a reversible splenial lesion. | Q48924245 | ||
| Severe form of acute influenza encephalopathy with biphasic seizures and late reduced diffusion. | Q49021447 | ||
| Transient isolated lesion of the splenium associated with clinically mild influenza encephalitis. | Q49023553 | ||
| Cytokines sing the blues: inflammation and the pathogenesis of depression | Q24633065 | ||
| Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants | Q28301511 | ||
| Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel. | Q30356803 | ||
| Acute necrotizing encephalopathy in a child with H1N1 influenza infection. | Q30383600 | ||
| Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic. | Q30384543 | ||
| Novel swine-origin influenza A (H1N1) viral encephalitis. | Q30386146 | ||
| Pandemic influenza A (H1N1) 2009 with neurological manifestations, a case series. | Q30388366 | ||
| Reversible splenial lesion associated with novel influenza A (H1N1) viral infection | Q30389184 | ||
| Complex febrile seizures followed by complete recovery in an infant with high-titer 2009 pandemic influenza A (H1N1) virus infection | Q30392534 | ||
| Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1): An Experience from a Tertiary Care Center in North India | Q30393086 | ||
| Neurologic manifestations of pediatric novel h1n1 influenza infection | Q30393240 | ||
| H1N1 Encephalitis with Malignant Edema and Review of Neurologic Complications from Influenza | Q30393249 | ||
| Heightened neurologic complications in children with pandemic H1N1 influenza | Q30394083 | ||
| Neurological complications of pandemic influenza (H1N1) in children. | Q30396739 | ||
| Pediatric neurological complications of 2009 pandemic influenza A (H1N1). | Q30397285 | ||
| Safety profile of oseltamivir during the 2009 influenza pandemic | Q30401279 | ||
| Parkinson's disease or Parkinson symptoms following seasonal influenza. | Q30403795 | ||
| Hypothalamic abnormalities and Parkinsonism associated with H1N1 influenza infection. | Q30496428 | ||
| Reversible splenial lesion in influenza virus encephalopathy | Q31137008 | ||
| Encephalitis and encephalopathy associated with an influenza epidemic in Japan | Q33343686 | ||
| Clinical and laboratory analysis of influenza B infection in children in Taichung, Taiwan during the 2006-2007 flu season | Q33384572 | ||
| Systemic inflammation and disease progression in Alzheimer disease | Q33765718 | ||
| Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. | Q33813321 | ||
| Oseltamivir dosing for influenza infection in premature neonates | Q33996464 | ||
| Oseltamivir: a clinical and pharmacological perspective | Q34515436 | ||
| Prognostic predictive values of serum cytochrome c, cytokines, and other laboratory measurements in acute encephalopathy with multiple organ failure | Q36153044 | ||
| Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries | Q36384299 | ||
| Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers | Q36932915 | ||
| Nuanced roles of cytokines in three major human brain disorders | Q36955568 | ||
| Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation | Q36964367 | ||
| Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. | Q36990293 | ||
| Neural-immune interactions in disorders of sleep-wakefulness organization | Q36995663 | ||
| Acute childhood encephalitis and encephalopathy associated with influenza: a prospective 11-year review | Q37132694 | ||
| Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin | Q37163881 | ||
| Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review | Q37331947 | ||
| Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system | Q37409972 | ||
| Posterior reversible encephalopathy syndrome and cerebral vasculopathy associated with influenza A infection: report of a case and review of the literature | Q37639080 | ||
| Clinical characteristics of Korean pediatric patients critically ill with influenza A (H1N1) virus | Q37774609 | ||
| Clinical features of hospitalised children with 2009 H1N1 influenza virus infection | Q40353080 | ||
| Acute necrotizing encephalopathy during novel influenza A (H1N1) virus infection. | Q40355459 | ||
| Rat model of influenza-associated encephalopathy (IAE): studies of electroencephalogram (EEG) in vivo | Q40374723 | ||
| Influenza-related hospitalisations in children | Q40376140 | ||
| Childhood encephalitis in Sweden: etiology, clinical presentation and outcome | Q40425663 | ||
| Thermal instability of compound variants of carnitine palmitoyltransferase II and impaired mitochondrial fuel utilization in influenza-associated encephalopathy | Q40425971 | ||
| Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza-associated encephalopathy | Q40511458 | ||
| A reversible lesion of the corpus callosum splenium with adult influenza-associated encephalitis/encephalopathy: a case report | Q40619274 | ||
| Dual roles for perivascular macrophages in immune-to-brain signaling | Q40665015 | ||
| Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. | Q41855140 | ||
| Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants | Q41972375 | ||
| Neuroexcitatory actions of Tamiflu and its carboxylate metabolite | Q42040386 | ||
| In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu) and active metabolite | Q42207854 | ||
| Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children | Q42647738 | ||
| Oseltamivir and abnormal behavior | Q42869110 | ||
| Novel influenza A (H1N1)-associated encephalopathy/encephalitis with severe neurological sequelae and unique image features--a case report | Q42876651 | ||
| Influenza a/h1n1 encephalitis | Q42936043 | ||
| Novel influenza A (H1N1) encephalitis in a 3-month-old infant | Q43092584 | ||
| Apoptosis and proinflammatory cytokine responses of primary mouse microglia and astrocytes induced by human H1N1 and avian H5N1 influenza viruses | Q43166340 | ||
| Hospitalization of children with influenza A(H1N1) virus in Israel during the 2009 outbreak in Israel: a multicenter survey | Q43173467 | ||
| Radiographic study of severe Influenza-A (H1N1) disease in children | Q43173501 | ||
| Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases | Q43173567 | ||
| Surveillance of H1N1-related neurological complications | Q43174357 | ||
| Influenza-associated central nervous system dysfunction in Taiwanese children: clinical characteristics and outcomes with and without administration of oseltamivir | Q43174972 | ||
| Oseltamivir and abnormal behaviors: true or not? | Q43175066 | ||
| Differences in clinical manifestations of influenza-associated encephalopathy by age. | Q43175088 | ||
| Prognostic factors in influenza-associated encephalopathy. | Q43175713 | ||
| Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan. | Q43175785 | ||
| Urinary organic metabolite screening of children with influenza-associated encephalopathy for inborn errors of metabolism using GC/MS. | Q43175837 | ||
| Premorbid factors and outcome associated with respiratory virus infections in a pediatric intensive care unit | Q43175873 | ||
| Adolescent jump case in Japan associated with influenza but not oseltamivir | Q43175907 | ||
| Neurologic complications in children hospitalized with influenza: comparison between USA and Hong Kong | Q43175980 | ||
| Encephalopathy associated with influenza epidemics | Q43209369 | ||
| Penetration of oseltamivir and its active metabolite into the brain after lipopolysaccharide-induced inflammation in mice | Q43265037 | ||
| Influenza A encephalopathy, cerebral vasculopathy, and posterior reversible encephalopathy syndrome: combined occurrence in a 3-year-old child | Q43779417 | ||
| Biodistribution and metabolism of the anti-influenza drug [11C]oseltamivir and its active metabolite [11C]Ro 64-0802 in mice | Q43889307 | ||
| Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic a | Q43908947 | ||
| Children hospitalized with 2009 novel influenza A(H1N1) in California | Q44266863 | ||
| Emergence of acute necrotising encephalopathy in Australia | Q44501456 | ||
| Acute encephalopathy associated with influenza C virus infection | Q45065114 | ||
| Influenza-associated encephalopathy: no evidence for neuroinvasion by influenza virus nor for reactivation of human herpesvirus 6 or 7. | Q45212356 | ||
| Lipopolysaccharide treatment and inoculation of influenza A virus results in influenza virus-associated encephalopathy-like changes in neonatal mice | Q45377207 | ||
| Oseltamivir treatment for children showing abnormal behavior during influenza virus infection | Q45386730 | ||
| Human influenza virus infection and apoptosis induction in human vascular endothelial cells | Q45395671 | ||
| Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy | Q45728393 | ||
| Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy | Q45736385 | ||
| The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza. | Q45969160 | ||
| Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver. | Q45987287 | ||
| Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment | Q46067070 | ||
| Acute ophthalmoparesis accompanied with Influenza A infection. | Q46363547 | ||
| Oseltamivir enhances hippocampal network synchronization | Q46651416 | ||
| Acute hemorrhagic leukoencephalitis and hypoxic brain injury associated with H1N1 influenza | Q48161198 | ||
| A 7-year-old boy dying of acute encephalopathy. | Q48214780 | ||
| Acute necrotizing encephalopathy in a child during the 2009 influenza A(H1N1) pandemia: MR imaging in diagnosis and follow-up | Q48271635 | ||
| Acute necrotizing encephalopathy progressing to brain death in a pediatric patient with novel influenza A (H1N1) infection | Q48277385 | ||
| Serum levels of cytokines and EEG findings in children with influenza associated with mild neurological complications | Q48280182 | ||
| Severe encephalopathy with swine origin influenza A H1N1 infection in childhood: case reports. | Q48285010 | ||
| Absence of adverse effects of oseltamivir on sleep: a double-blind, randomized study in healthy volunteers in Japan | Q48302381 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oseltamivir | Q211509 |
| P304 | page(s) | 826-848 | |
| P577 | publication date | 2012-10-02 | |
| P1433 | published in | Advances in Therapy | Q4686392 |
| P1476 | title | Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review | |
| P478 | volume | 29 |
| Q35737905 | Analysis of a child who developed abnormal neuropsychiatric symptoms after administration of oseltamivir: a case report. |
| Q39118405 | Antiviral Treatments |
| Q33776771 | Influenza vaccination and treatment in children with neurologic disorders |
| Q35680207 | Life-Threatening Abnormal Behavior Incidence in 10-19 Year Old Patients Administered Neuraminidase Inhibitors |
| Q28709580 | National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic |
| Q64066438 | Neuropsychiatric events in an adult patient with influenza a (H3N2) treated with oseltamivir (Tamiflu): a case report |
| Q38652336 | Oseltamivir for influenza infection in children: risks and benefits |
| Q64993860 | Oseltamivir induced Stevens-Johnson syndrome/toxic epidermal necrolysis-case report. |
| Q40042917 | Oseltamivir use and severe abnormal behavior in Japanese children and adolescents with influenza: Is a self-controlled case series study applicable? |
| Q40500528 | Pharmacokinetic Modeling and Monte Carlo Simulation to Predict Interindividual Variability in Human Exposure to Oseltamivir and Its Active Metabolite, Ro 64-0802. |
Search more.